Patents by Inventor Anthony Cuzzupe

Anthony Cuzzupe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Benzodiazepines as bromodomain inhibitors
    Patent number: 10167292
    Abstract: The present invention provides novel benzodiazepine derivatives of Formula I or pharmaceutically acceptable derivatives, polymorphs, salts or prodrugs thereof. Said compounds have potential as bromodomain (BRD) inhibitors.
    Type: Grant
    Filed: August 4, 2016
    Date of Patent: January 1, 2019
    Assignee: Catalyst Therapeutics Pty Ltd.
    Inventors: Chris Burns, Jean-Marc Garnier, Phillip Patrick Sharp, John Feutrill, Anthony Cuzzupe
  • Benzodiazepines as bromodomain inhibitors
    Publication number: 20180230153
    Abstract: The present invention provides novel benzodiazepine derivatives of Formula I or pharmaceutically acceptable derivatives, polymorphs, salts or prodrugs thereof. Said compounds have potential as bromodomain (BRD) inhibitors.
    Type: Application
    Filed: August 4, 2016
    Publication date: August 16, 2018
    Inventors: Chris Burns, Jean-Marc Garnier, Phillip Patrick Sharp, John Feutrill, Anthony Cuzzupe
  • FUNCTIONALISED AND SUBSTITUTED INDOLES AS ANTI-CANCER AGENTS
    Publication number: 20170166555
    Abstract: The present invention relates to anti-tropomyosin compounds, processes for their preparation, and methods for treating or preventing a proliferative disease, preferably cancer, using compounds of the invention.
    Type: Application
    Filed: November 25, 2014
    Publication date: June 15, 2017
    Inventors: Ian James, Ian Dixon, John Feutrill, Anthony Cuzzupe, Herbert Treutlein, Jun Zeng, Tracy Nero, Peter Gunning